Compass Pathways Announces Pricing of $150 Million Public Offering Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants [...]
Hamilton Lane’s Erik Hirsch: We’re seeing a private credit witch hunt Markets Depending on which central banking chief you talk to, the burgeoning private credit industry is either a cause of insomnia, a “dark corner” of finance or an arcane lending practice whose participants are behaving like bankers in the run-up to the global financial crisis. To Hamilton Lane boss Erik Hirsch, though, it is simply an [...]
Why the Tory Party tried to persuade Karren Brady to run for London mayor Opinion The Tories need a political heavyweight to come forward and run for mayor. We once tried but to no avail, writes Giles Kenningham
Janus Henderson Announces Acquisition of Richard Bernstein Advisors January 23, 2026 Richard Bernstein Advisors (RBA) is a research-driven, macro multi-asset investment manager delivering differentiated investment solutions, overseeing approximately $20 billion in client assets1 Acquisition positions Janus Henderson as a leading model portfolio and separately managed account (SMA) provider
Janus Henderson Group plc to be Acquired by Trian Fund Management and General Catalyst for $7.4 Billion December 22, 2025 Janus Henderson Shareholders to Receive $49.00 per Share in Cash Transaction Represents a Premium of 18% to the Unaffected Closing Price on October 24, 2025 Significant Long-Term Investment to Be Made in Product Offerings, Client Services, Technology, and Talent
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months November 4, 2025 Company accelerating commercialization readiness plans by 9-12 months, following completion of COMP006 trial enrollment and positive meeting with FDA on NDA submission strategies for COMP360 in TRD, including potential rolling submission Company now plans to disclose 9-week data (Part A) from COMP006 together with 26-week data (Part B) from COMP005 in Q1 2026 Disclosure of 26-week (Part B) COMP006 data expected in early Q3 2026 Cash position of $185.9 million as of September 30, 2025 Conference call on November 4 at 8 am ET (1 pm UK)
How AXA UK&I boss is building a £7bn insurance powerhouse September 16, 2025 If AXA UK&I was listed on the London Stock Exchange in its own right, it would be part of the FTSE 100, its chief executive Tara Foley has said. The AXA group is one of France’s best-known financial services firms, and its financials reflect this, having generated over €110bn (£95bn) in 2024. While back at [...]
How the wellness bro came to rule the City July 31, 2025 As finance bros roam the City clutching pink smoothies, Anna Moloney examines the changing culture of health and rise of the wellness bro.
I sold my business for £1.5bn – with great wealth comes great responsibility July 10, 2025 Those of us fortunate enough to thrive at the top must do more to support those struggling at the bottom, not out of guilt or obligation, but because it is the right thing to do and makes us richer in meaning, purpose and legacy, says John Caudwell This week I had the honour of speaking [...]
India-Pakistan, England cricket chiefs and sport’s moral compass May 15, 2025 The ECB will be grateful that it has not yet had cause to reach for its moral compass in the India-Pakistan conflict, writes Ed Warner. I was in Paris at the 2022 Wheelchair Rugby Euros when Russia invaded Ukraine. The very next day’s results show Russia beating Poland 1-0. This in a sport in which [...]